To include your compound in the COVID-19 Resource Center, submit it here.

Meda, Valeant in deal for topical drugs

Meda AB (SSE:MEDAA) granted Valeant Pharmaceuticals International Inc. (NYSE:VRX; TSX:VRX) exclusive rights in North America to topical

Read the full 172 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE